AHA advocates for stronger health care supply chain in comments for House subcommittee hearing

Jun 11, 2025 - 03:20 PM
US Capitol with flag 900 x 400

The AHA submitted a statement today to the House Energy and Commerce Subcommittee on Health for a hearing today on the health care supply chain. The AHA advocated for strengthening the health care supply chain while acknowledging significant time would be needed due to logistical complexities and resources needed to do so. 
 
Additionally, the AHA noted that pharmaceuticals sourced from overseas are significantly important for patients, such as cancer and cardiovascular medications, immunosuppressives, antibiotics and combination antibiotics. The AHA also reiterated its support for the Mapping America’s Pharmaceutical Supply Act (S. 1784), legislation that would require the Department of Health and Human Services to perform a comprehensive risk assessment of the entire U.S. pharmaceutical supply chain. 

Related News Articles

Headline
AHA expresses concerns on potential tariffs for PPE, other medical goods
The AHA urged the Department of Commerce Oct. 17 to take a balanced approach to ensuring dependable and affordable access to personal protective equipment,…
Headline
Resource hub features tools, information on tariffs impacting health care supply chain
The AHA’s Association for Health Care Resource & Materials Management has created a webpage featuring resources on tariffs impacting the health care supply…
Headline
AHA calls for Senate committee to strengthen supply chain for pharmaceuticals, medical devices
The AHA provided a statement of record to the Senate Special Committee on Aging for a hearing Oct. 8 on the pharmaceutical and medical device supply chains.…
Headline
President announces new tariffs, including for certain pharmaceuticals, set to begin Oct. 1 
President Trump, late Sept. 25, announced that starting Oct. 1, the U.S. will impose a 100% tariff on any branded or patented pharmaceutical product, unless a…
Headline
Commerce Department seeks comment on investigation of imported PPE, medical equipment for possible tariffs 
The Department of Commerce Sept. 24 released a notice seeking public comment on an investigation it launched Sept. 2 on imports of personal protective…
Headline
FDA issues Class I recall for Olympus endoscope needles
The Food and Drug Administration has identified a Class I recall of certain Olympus ViziShot 2 FLEX Needles due to a possible patient safety issue caused by a…